 |
|
|
| |
All-Oral Therapy With Daclatasvir in Combination With Asunaprevir and BMS-791325 for Treatment-Naive Patients With Chronic HCV Genotype 4 Infection
|
| |
| |
Reported by Jules Levin
Digestive Disease Week
Chicago, IL, May 3-6, 2014
Hassanein T,1 Everson G,2 Sims KD,3 Bennett M,4 Gitlin N,5 Lawitz E,6 Nguyen T,7 Webster L,8 Younossi Z,9 Schwartz H,10 Thuluvath PJ,11 Zhou H,12 Rege B,3 McPhee F,13 Zhou, N,13 Wind-Rotolo M,12 Chung E,3 Griffies A,3 Grasela DM,3 Gardiner DF3
1Southern California Liver Centers, Coronado, CA; 2University of Colorado Denver, Aurora, CO; 3Bristol-Myers Squibb, Hopewell, NJ; 4Medical Associates Research Group, San Diego, CA; 5Atlanta Gastroenterology Associates, Atlanta, GA; 6The Texas Liver Institute, University of Texas Health Science Center, San Antonio, TX; 7Research and Education Inc, San Diego, CA; 8CRI Lifetree, Salt Lake City, UT; 9Inova Fairfax Hospital, Center for Liver Diseases, Falls Church, VA; 10Miami Research Associates, South Miami, FL; 11Mercy Medical Center, Baltimore MD; 12Bristol-Squibb Princeton NJ; 13Bristol-Squibb Wallingford CT
|
| |
|
|
|
|
|
